Literature DB >> 2383025

Tumor necrosis factor enhances GD3 ganglioside expression in cultured human melanocytes.

K Furukawa1, Y Arita, N Satomi, M Eisinger, K O Lloyd.   

Abstract

Human skin melanocytes and melanocytes cultured in vitro express GM3 ganglioside almost exclusively, whereas malignant melanomas express high levels of both GM3 and GD3. We now show that treatment of cultured melanocytes with tumor necrosis factor-alpha, particularly in the presence of tetradecanoylphorbol-13-acetate, results in a change in morphology from spindle-shaped to epithelioid and greatly enhanced expression of GD3 ganglioside. This effect is specific and no other ganglioside is affected, except that GM3 expression (which is already high) is also increased. In contrast, these agents did not enhance the already high expression of GD3 on melanoma cells. This result provides an example of the plasticity of glycolipid expression in mammalian cells and their susceptibility to the influence of biological agents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2383025     DOI: 10.1016/0003-9861(90)90414-t

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

Review 1.  Biosynthesis and functions of gangliosides: recent advances.

Authors:  K O Lloyd; K Furukawa
Journal:  Glycoconj J       Date:  1998-07       Impact factor: 2.916

2.  Expression cloning of a CMP-NeuAc:NeuAc alpha 2-3Gal beta 1-4Glc beta 1-1'Cer alpha 2,8-sialyltransferase (GD3 synthase) from human melanoma cells.

Authors:  K Nara; Y Watanabe; K Maruyama; K Kasahara; Y Nagai; Y Sanai
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

3.  Expression of alpha 2,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation in activated T lymphocytes.

Authors:  S Yamashiro; M Okada; M Haraguchi; K Furukawa; K O Lloyd; H Shiku; K Furukawa
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

4.  Ganglioside composition of the rat choriocarcinoma cell line, Rcho-1.

Authors:  T Shirai; S Itonori; T Tai; M J Soares; K Shiota; T Ogawa
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

5.  Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system.

Authors:  K Takamiya; A Yamamoto; K Furukawa; S Yamashiro; M Shin; M Okada; S Fukumoto; M Haraguchi; N Takeda; K Fujimura; M Sakae; M Kishikawa; H Shiku; K Furukawa; S Aizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

6.  Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures.

Authors:  M Rusnati; E Tanghetti; C Urbinati; G Tulipano; S Marchesini; M Ziche; M Presta
Journal:  Mol Biol Cell       Date:  1999-02       Impact factor: 4.138

Review 7.  Role of Cytokine-Induced Glycosylation Changes in Regulating Cell Interactions and Cell Signaling in Inflammatory Diseases and Cancer.

Authors:  Justine H Dewald; Florent Colomb; Marie Bobowski-Gerard; Sophie Groux-Degroote; Philippe Delannoy
Journal:  Cells       Date:  2016-11-29       Impact factor: 6.600

8.  Epigenetic hypomethylation and upregulation of GD3s in triple negative breast cancer.

Authors:  Wan Li; Xiangjin Zheng; Liwen Ren; Weiqi Fu; Jinyi Liu; Jun Xv; Shiwei Liu; Jinhua Wang; Guanhua Du
Journal:  Ann Transl Med       Date:  2019-12

Review 9.  O-acetylated Gangliosides as Targets for Cancer Immunotherapy.

Authors:  Sumeyye Cavdarli; Philippe Delannoy; Sophie Groux-Degroote
Journal:  Cells       Date:  2020-03-17       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.